Literature DB >> 19755760

Relationship between serum bilirubin and carotid atherosclerosis in hypertensive patients.

Xia-Feng Yang1, Yuan-Zhi Chen, Jiang-Li Su, Feng-Yun Wang, Le-Xin Wang.   

Abstract

OBJECTIVE: To investigate the relationship between serum bilirubin and carotid atherosclerosis in patients with hypertension. PATIENTS AND METHODS: Carotid artery ultrasonography was performed in 198 patients (104 males, average age of 65.6+/-7.1 years) with hypertension. Serum levels of bilirubin and C-reactive proteins (CRP) were measured at the same time.
RESULTS: Carotid atherosclerosis was detected in 133 patients, 87 of them had carotid artery plaque. The prevalence of stroke (20.3%) and myocardial infarction (13.5%) in the atherosclerosis group was higher than in the non-atherosclerosis group (9.2% and 6.2%, respectively, p<0.05). The average total serum bilirubin in the atherosclerosis group was lower than in the non-atherosclerosis group (12.8+/-1.3 vs 16.8+/-1.5 micromol/L, p<0.01), whereas the average serum of CRP was higher (4.1+/-1.1 vs 2.3+/-0.7 mg/L, p<0.01). After adjusting other factors such as age, total cholesterol, diabetes and systolic blood pressure, total serum bilirubin was negatively associated with carotid atherosclerosis in women and men, with odds ratios of 0.49 (95% CI, 0.28 to 0.71; p<0.01) and 0.66 (95% CI, 0.46 to 0.80; p<0.01). Serum CRP was positively correlated to carotid atherosclerosis, with odds ratios of 1.76 (95% CI, 1.36 to 2.04; p<0.01) in women and 1.95 (95% CI, 1.46 to 2.82; p<0.01) in men.
CONCLUSION: Carotid atherosclerosis was associated with a high prevalence of stroke or myocardial infarction in hypertensive patients. Serum bilirubin was negatively associated with carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755760     DOI: 10.2169/internalmedicine.48.2286

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

2.  Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.

Authors:  Satoshi Yoshino; Shuichi Hamasaki; Sanemasa Ishida; Tetsuro Kataoka; Akiko Yoshikawa; Naoya Oketani; Keishi Saihara; Hitoshi Ichiki; So Kuwahata; Shoji Fujita; Takuro Takumi; Issei Yoshimoto; Mitsuhiro Nakazaki; Chuwa Tei
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

Review 3.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

4.  Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.

Authors:  Leon Fisher; Wichat Srikusalanukul; Alexander Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

5.  Mildly elevated serum bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons.

Authors:  Ryuichi Kawamoto; Daisuke Ninomiya; Yoichi Hasegawa; Yoshihisa Kasai; Tomo Kusunoki; Nobuyuki Ohtsuka; Teru Kumagi; Masanori Abe
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

Review 6.  Research Progress on the Risk Factors and Outcomes of Human Carotid Atherosclerotic Plaques.

Authors:  Xiang-Dong Xiong; Wei-Dong Xiong; Shang-Shen Xiong; Gui-Hai Chen
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

7.  Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease.

Authors:  Jonguk Kim; Seung-Jae Yoon; Min-Hee Woo; Sang-Heum Kim; Nam-Keun Kim; Jinkwon Kim; Ok-Joon Kim; Seung-Hun Oh
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

8.  Biliverdin protects against liver ischemia reperfusion injury in swine.

Authors:  Barbara Andria; Adele Bracco; Chiara Attanasio; Sigismondo Castaldo; Maria Grazia Cerrito; Santolo Cozzolino; Daniele Di Napoli; Roberto Giovannoni; Antonio Mancini; Antonino Musumeci; Ernesto Mezza; Mario Nasti; Vincenzo Scuderi; Stefania Staibano; Marialuisa Lavitrano; Leo E Otterbein; Fulvio Calise
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Higher serum direct bilirubin levels were associated with a lower risk of incident chronic kidney disease in middle aged Korean men.

Authors:  Seungho Ryu; Yoosoo Chang; Yiyi Zhang; Hee-Yeon Woo; Min-Jung Kwon; Hyosoon Park; Kyu-Beck Lee; Hee Jung Son; Juhee Cho; Eliseo Guallar
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Bilirubin Binding to PPARα Inhibits Lipid Accumulation.

Authors:  David E Stec; Kezia John; Christopher J Trabbic; Amarjit Luniwal; Michael W Hankins; Justin Baum; Terry D Hinds
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.